INS and hypertensive disorder: An analysis assessing treatment effect on the primary end point adjusted for BMI, number of medications at baseline, 10-year Framingham risk score, basal insulin level at baseline, and duration of hypertension found similar results with a rate ratio of 6.4 (95% CI, 3.1–13.0; P<0.001).